新芝生物
(920685)
| 流通市值：6.78亿 | | | 总市值：10.63亿 |
| 流通股本：5831.40万 | | | 总股本：9151.60万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 | 114,171,509.27 |
| 营业收入 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 | 114,171,509.27 |
| 二、营业总成本 | 68,876,287.87 | 29,363,681.61 | 129,940,626.36 | 92,159,963.11 |
| 营业成本 | 31,442,084.75 | 13,003,912.84 | 62,457,166.53 | 42,583,622.74 |
| 税金及附加 | 1,210,925.19 | 416,161.95 | 2,188,803.36 | 1,661,784.89 |
| 销售费用 | 16,238,583.1 | 6,682,766.85 | 26,301,810.67 | 18,863,955.5 |
| 管理费用 | 10,710,099.11 | 5,019,862.49 | 21,310,569.02 | 16,470,640.77 |
| 研发费用 | 9,476,454.1 | 4,398,369.45 | 18,212,037.99 | 13,102,305.8 |
| 财务费用 | -201,858.38 | -157,391.97 | -529,761.21 | -522,346.59 |
| 其中:利息费用 | 122,947.87 | 63,957.34 | 167,619.5 | 128,067.12 |
| 其中:利息收入 | 793,147.76 | 442,004.84 | 882,333.02 | 694,504.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,450,821.09 | 834,471.86 | 3,377,216.92 | 2,425,059.92 |
| 加:投资收益 | 904,942.22 | 184,017.02 | 1,901,592.31 | 1,696,820.57 |
| 资产处置收益 | - | 0 | 145,904.27 | - |
| 资产减值损失(新) | -1,058,989.41 | -854,303.58 | -3,098,757.73 | -1,122,985.11 |
| 信用减值损失(新) | -363,683.8 | -48,749.6 | -475,840.75 | -238,534.63 |
| 其他收益 | 4,971,873.21 | 3,163,285.15 | 7,316,819.61 | 4,577,109.14 |
| 四、营业利润 | 20,882,834.23 | 8,806,570.53 | 48,951,172.5 | 29,349,016.05 |
| 加:营业外收入 | 21,494.74 | 13,278.26 | 65,678.03 | 35,654.02 |
| 减:营业外支出 | 162,778.91 | 7,630.08 | 351,354.24 | 55,662.02 |
| 五、利润总额 | 20,741,550.06 | 8,812,218.71 | 48,665,496.29 | 29,329,008.05 |
| 减:所得税费用 | 1,912,413.18 | 533,037.44 | 4,966,359.65 | 2,495,868.07 |
| 六、净利润 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 14,821,831.89 | 6,957,831.91 | 35,204,715.35 | 20,709,090.01 |
| 少数股东损益 | 4,007,304.99 | 1,321,349.36 | 8,494,421.29 | 6,124,049.97 |
| 扣除非经常损益后的净利润 | 11,567,448.12 | 4,785,518.62 | 29,070,801.85 | 15,530,837.13 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.17 | 0.08 | 0.4 | 0.23 |
| (二)稀释每股收益 | 0.17 | 0.08 | 0.4 | 0.23 |
| 九、综合收益总额 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 |
| 归属于母公司股东的综合收益总额 | 14,821,831.89 | 6,957,831.91 | 35,204,715.35 | 20,709,090.01 |
| 归属于少数股东的综合收益总额 | 4,007,304.99 | 1,321,349.36 | 8,494,421.29 | 6,124,049.97 |
| 公告日期 | 2026-08-26 | 2026-04-27 | 2026-04-27 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |